InvestorsHub Logo
icon url

032798

03/30/10 11:21 AM

#179 RE: Potse #178

Potse,

I just find it rather interesting that some of the shells you have mentioned to support your decision to sell your CCKH position have/had share structures and market caps significantly higher than CCKH. Personally, the fact that ASMH (40+M shares, $1.5M debt on the books) underwent a share reorganization doesn't make me want to sell my CCKH position, regardless of any potential reverse split.

This supports the reason why you do not understand where I am coming from. And shows our differing paradigms.

Good Luck to you,

Regards,
03
icon url

DesertRat1

03/31/10 11:21 AM

#180 RE: Potse #178

Potse, what's your take on the fact that the company name was changed with the Nevada Secretary of State immediately upon the Meuse purchase?
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=OdNv1UJOpnPjO7j24XQ9Tg%253d%253d&nt7=0

I noticed that with ACTN, even though they have filed with the SEC disclosing a merger deal, the name has not yet changed with Nevada.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=CTvicw03COexjKJRzY19nQ%253d%253d&nt7=0

It seems to imply that Meuse might have different intentions with CCKH, or perhaps something was already in the works as control was acquired.

Also, I'm not sure if its completely coincidental, but the new name of CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC. sort of still fits the ticker symbol CCKH. Maybe that's a stretch, I don't know.